Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지

2009 Pandemic Influenza A(H1N1) Infections in the Pediatric Cancer Patients and Comparative Analysis with Seasonal Influenza

소아암 환자에서 2009 대유행 인플루엔자 A(H1N1) 감염의 임상적 고찰 및 계절 인플루엔자와의 비교 분석

  • 최수한 (삼성서울병원 소아청소년과) ;
  • 유건희 (삼성서울병원 소아청소년과) ;
  • 안강모 (삼성서울병원 소아청소년과) ;
  • 성기웅 (삼성서울병원 소아청소년과) ;
  • 구홍회 (삼성서울병원 소아청소년과) ;
  • 김예진 (삼성서울병원 소아청소년과)
  • Received : 2011.12.28
  • Accepted : 2012.02.16
  • Published : 2012.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was performed to compare the clinical characteristics of 2009 pandemic influenza A(H1N1) [A(H1N1) pdm09] and seasonal influenza A infection in the pediatric cancer patients. Methods: A retrospective review was performed in the pediatric cancer patients who had confirmed A(H1N1)pdm09 infection at Samsung Medical Center from August 2009 to February 2010. For the comparison, the medical records of pediatric cancer patients with seasonal influenza A from January 2000 to May 2009 were reviewed retrospectively. Results: Eighty-two A(H1N1)pdm09 infections were confirmed in the pediatric cancer patients. Ten patients (12.2%) developed complicated clinical course by lower respiratory infections or extrapulmonary infections; 4 pneumonia, 1 bronchitis, 1 pericarditis with pneumonia, 1 encephalitis with pneumonia, 2 meningitis and 1 pericarditis. Three patients received mechanical ventilator and ICU care. Three pediatric cancer patients (3.7%) died. The risk factors related to complicated A(H1N1)pdm09 infections were date of infection (44-45th week 2009) and nosocomial infection. When comparing with previous seasonal influenza A infections, more prompt and aggressive antiviral therapy was given in A(H1N1)pdm09 infections. Conclusion: The A(H1N1)pdm09 infections caused a various clinical manifestations including fatal cases in pediatric cancer patient during pandemic season. There was no significant difference in clinical course between influenza A(H1N1)pdm09 and seasonal influenza A infections except the antiviral treatment strategy.

목적: 본 연구는 단일 기관에서 소아암 환자의 2009 인플루엔자 A(H1N1) [A(H1N1)pdm09] 감염 양상을 조사하고 이전의 계절 인플루엔자 감염과 비교 분석하고자 하였다. 방법: 삼성서울병원에서 2009년 8월부터 2010년 2월까지 A(H1N1)pdm09 감염, 2000년 1월부터 2009년 5월까지 계절 인플루엔자 A 감염이 확진된 소아암 환자의 의무기록을 후향적으로 분석하였다. 결과: 82명의 소아암 환자에서 A(H1N1)pdm09 감염이 확진되었다. 10명(12.2%)의 환자에서 하기도 감염증 또는 호흡기 외 감염이 발생하였다. 3명(3.7%)의 환자가 사망하였고 그 중 2명은 A(H1N1)pdm09 기여 사망이었다. 합병된 감염증과 관련하여 유의성을 가지는 위험인자는 감염의 시점(2009년 44-45주)과 병원 내 감염이었다. 이전의 계절 인플루엔자 A 감염과 비교하였을 때 임상적 특성에는 유의한 차이가 없었으나 A(H1N1) pdm09 감염에서 적극적인 항바이러스제 치료가 시행되었다. 결론: 소아암 환자에서 A(H1N1)pdm 감염은 경증부터 중증까지 다양한 임상 경과를 보였으며 이전의 계절 인플루엔자와 비교했을 때 임상 양상의 유의한 차이는 없었다.

Keywords

References

  1. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children-- Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-2.
  2. WHO. World now at the start of Pandemic influenza. Available at http://www.who.int/mediacentre/news/ statements/2009/h1n1_pandemic_phase6_20090611/en /[accessed on 27 Nov 2011]
  3. Available at http://cdc.gov/h1n1flu/estimates_2009_ h1n1.htm [accessed on 27 Dec 2011]
  4. Kim JH, Yoo HS, Lee JS, Lee EG, Park HK, Sung YH, et al. The spread of pandemic H1N1 2009 by age and region and the comparison among monitoring tools. J Korean Med Sci 2010;25:1109-12. https://doi.org/10.3346/jkms.2010.25.7.1109
  5. Cowling BJ, Chan KH, Fang VJ, Lau LL, So HC, Fung RO, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-84. https://doi.org/10.1056/NEJMoa0911530
  6. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-19. https://doi.org/10.1056/NEJMra1000449
  7. Lessler J, Reich NG, Cummings DA, Nair HP, Jordan HT, Thompson N. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009;361:2628-36. https://doi.org/10.1056/NEJMoa0906089
  8. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44. https://doi.org/10.1056/NEJMoa0906695
  9. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-9. https://doi.org/10.1056/NEJMoa0904023
  10. Rihani R, Hayajneh W, Sultan I, Ghatasheh L, Abdel- Rahman F, Hussein N, et al. Infections with the 2009 H1N 1 influenza virus among hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 2011;46:1430-6. https://doi.org/10.1038/bmt.2010.329
  11. Espinosa-Aguilar L, Green JS, Forrest GN, Ball ED, Maziarz RT, Strasfeld L, et al. Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences. Biol Blood Marrow Transplant 2011; 17:566-73. https://doi.org/10.1016/j.bbmt.2010.07.018
  12. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010;60:257-63. https://doi.org/10.1016/j.jinf.2010.01.009
  13. Standardization of terminology of the Pandemic A (H1N1) 2009 Virus. Availabe at http://who.int/ influenza/gisrs_laboratory/terminology_ah1n1pdm09 /en/ [accessed on 26 Nov 2011].
  14. Korea Centers for Disease Control and Prevention. Influenza sentinel surveillance report. Available at http:// www.cdc.go.kr/ [accessed on 26 Nov 2011]
  15. WHO/CDS/CSR/EPH/2002.12. Prevention of hospitalacquired infection. Available at http://www.who.int/ csr/resources/publications/drugresist/en/whocdsreph20 0212.pdf [accessed on 3 Feb 2012]
  16. Kang SJ, Lee JM, Hah JO, Shim YJ, Lee KS, Shin HJ, et al. Novel influenza A (H1N1) 2009 infection in the pediatric patients with hematologic and oncologic diseases in the Yeungnam region. Korean J Pediatr 2011;54:117- 22. https://doi.org/10.3345/kjp.2011.54.3.117
  17. Cost C, Brock E, Adams-Huet B, Siegel JD, Ardura MI. 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer 2011;56:127-33. https://doi.org/10.1002/pbc.22771
  18. Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011;117: 5050-6. https://doi.org/10.1182/blood-2010-11-319186
  19. Seiter K, Nadelman RB, Liu D, Ahmed T, Montecalvo MA. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2010;28:e27-9. https://doi.org/10.1200/JCO.2009.25.8889
  20. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004;39:1300-6. https://doi.org/10.1086/425004
  21. Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009;199:1435-41. https://doi.org/10.1086/598684
  22. Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood 2010; 115:1331-42. https://doi.org/10.1182/blood-2009-11-255455
  23. WHO. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Available at http://www.who.int/csr/ resources/publications/swineflu/h1n1_use_antivirals_2 0090820/en [accessed on 3 Feb 2012]
  24. Paganini H, Parra A, Ruvinsky S, Viale D, Baumeister E, Bologna R, et al. Clinical features and outcome of 2009 influenza A (H1N1) virus infections in children with malignant diseases: a case-control study. J Pediatr Hematol Oncol 2011;33:e5-8. https://doi.org/10.1097/MPH.0b013e3181f73f68